Bishop Ranch 6
2410 Camino Ramon, Suite 163
San Ramon, CA 94583
Tel: 925-543-0018 Toll Free: 800-433-7105
Fax: 925-275-2136
Email: sales@australbiologicals.com
www.australbiologicals.com

AUSTRAL Biologicals Catalog

Product Sheet: Rabbit anti-Human Cullin1 (CUL 1) IgG fraction polyclonal antibody

Catalog NumberPCA-2000a-9
Product IdPCA-2000a-9
Product NameRabbit anti-Human Cullin1 (CUL 1) IgG fraction polyclonal antibody
Temperature-20°C
Unit1mg
Price425
AvailabilityAvailable
CategoryGrowth Factors, Cytokines, Receptors and their Antibodies
SubcategoryPolyclonal Antibodies (Cancer/Apoptosis)
DescriptionIgG fraction from rabbit polyclonal antibody obtained by immunizing rabbits with a synthetic peptide (DGEKDTYSYLA) corresponding to amino acids 742-752 of human Cullin 1. The IgG fraction was purified using Protein G-Sepharose.
IsotypeN/A
Mol WeightN/A
PurityN/A
StorageStore at -20ºC.
StabilityStable at least one year at -20ºC. Avoid repeated freezing and thawing.
Biological ActivityThis polyclonal antibody reacts in ELISA (1:50 dilution) using the immunizing peptide. Cullins (1, 2, 3, 4a, 5 and 7) are a family of proteins that assemble a large number of ubiquitin ligases to catalyse polyubiquitiation, as well as binding to various specific factors to recruit substrates. Cullin 1 (CUL 1) is an essential component of SCF E3 Ubiquitin ligase complex which mediates the ubiquitation of proteins involved in cell cycle progression, signal transduction and transcription.
FormulationSolution at 1 mg/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.
ReferencesMichel, J.J. & Xiong, Y. (1998) Cell Growth Differ. 9, 435-449. Zheng, N. et al. (2002) Nature 416, 703-709. Jackson, P.K. & Eldridge, A.G. (2002) Mol. Cell. 9, 923-925.
All products are for research use ONLY in laboratory animals and in vitro testing. NOT for diagnostic or human use.

©1997-2024 AUSTRAL Biologicals Online|design + programming mcart group|Updated: 2022-03-21 18:12 GMT|